This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Personalized External Aortic Root Support Surgery for Asymptomatic Aortic Dilation: 100 Patient Milestone Reached
Golesworthy, Tal; Exstent, Ltd. (2017): Personalized External Aortic Root Support Surgery for Asymptomatic Aortic Dilation: 100 Patient Milestone Reached.
CTSNet, Inc. https://doi.org/10.25373/ctsnet.5510248
Retrieved: 19:33, Oct 18, 2017 (GMT)
Personalized External Aortic Root Support (PEARS) surgery was started in 2004 at the Royal Brompton Hospital, London, and has now been used to treat over 100 patients with asymptomatic aortic dilation related to Marfan Syndrome, Loeys-Dietz Syndrome, Bicuspid Aortic Valve disease, Turner's Syndrome, and various other congenital conditions involving asymptomatic aortic dilation. It retains all of the native structures, but reinforces the aortic root to halt dilation. In this video, PEARS inventor and first patient, Tal Golesworthy, interviews the 100th PEARS patient.
Disclosure: Tal Golesworthy is the inventor of PEARS and was the first recipient of a PEARS implant with respect to his own Marfanoid aorta. Mr Golesworthy is a director and shareholder of Exstent, Ltd, which makes the ExoVasc® Personalized External Aortic Root Support.